These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 1376397)

  • 21. Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B.
    Musch E; Högemann B; Gerritzen A; Fischer HP; Wiese M; Kruis W; Malek M; Gugler R; Schmidt G; Huchzermeyer H; Gerlach U; Dengler HJ; Sauerbruch T
    Hepatogastroenterology; 1998; 45(24):2282-94. PubMed ID: 9951911
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Interferon therapy in hematologic neoplasms].
    Schwarzinger I; Bettelheim P; Lechner K
    Wien Klin Wochenschr; 1988 Aug; 100(15):497-504. PubMed ID: 2459854
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monitoring of endogenous interferon-alpha and human herpesvirus 8 in HIV-infected patients with Kaposi's sarcoma.
    Plettenberg A; Albrecht D; Lorenzen T; Meyer T; Arndt R; Stoehr A
    Eur J Med Res; 2002 Jan; 7(1):19-24. PubMed ID: 11827836
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Antineoplastic effects of interferons].
    Shimoyama M
    Nihon Rinsho; 1986 Feb; 44(2):395-402. PubMed ID: 2422409
    [No Abstract]   [Full Text] [Related]  

  • 25. The Use of Interferons in the Treatment of Cutaneous T-Cell Lymphoma.
    Spaccarelli N; Rook AH
    Dermatol Clin; 2015 Oct; 33(4):731-45. PubMed ID: 26433845
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term follow-up of non-HIV Kaposi's sarcoma treated with low-dose recombinant interferon alfa-2b.
    Costa da Cunha CS; Lebbe C; Rybojad M; Agbalika F; Ferchal F; Rabian C; Vignon-Pennamen MD; Calvo F; Morel P
    Arch Dermatol; 1996 Mar; 132(3):285-90. PubMed ID: 8607632
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interferon treatment of renal cell carcinoma. Current status and future prospects.
    Krown SE
    Cancer; 1987 Feb; 59(3 Suppl):647-51. PubMed ID: 10822464
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Interferons and interferon therapy].
    Strander H
    Nord Med; 1992; 107(3):70-1. PubMed ID: 1372403
    [No Abstract]   [Full Text] [Related]  

  • 29. The interferons. Mechanisms of action and clinical applications.
    Baron S; Tyring SK; Fleischmann WR; Coppenhaver DH; Niesel DW; Klimpel GR; Stanton GJ; Hughes TK
    JAMA; 1991 Sep; 266(10):1375-83. PubMed ID: 1715409
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Perspectives of cytokine treatment in malignant skin tumors.
    Garbe C
    Recent Results Cancer Res; 1995; 139():349-69. PubMed ID: 7597303
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized, double-blind, placebo-controlled trial of systemically administered interferon-alpha, -beta, or -gamma in combination with cryotherapy for the treatment of condyloma acuminatum.
    Bonnez W; Oakes D; Bailey-Farchione A; Choi A; Hallahan D; Pappas P; Holloway M; Corey L; Barnum G; Dunne A
    J Infect Dis; 1995 May; 171(5):1081-9. PubMed ID: 7538546
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic hepatitis B and C. What is the status of drug therapy?
    Wright TL
    Postgrad Med; 1992 Sep; 92(4):75-82. PubMed ID: 1382288
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interferons in dermatology.
    Stadler R; Mayer-da-Silva A; Bratzke B; Garbe C; Orfanos C
    J Am Acad Dermatol; 1989 Apr; 20(4):650-6. PubMed ID: 2497154
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interferons in HIV and related diseases.
    Lane HC
    AIDS; 1994 Sep; 8 Suppl 3():S19-23. PubMed ID: 7840912
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interferon: current and future clinical uses in infectious disease practice.
    Main J; Handley J
    Int J STD AIDS; 1992; 3(1):4-9. PubMed ID: 1543767
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical use of biologic response modifiers in cancer treatment: an overview. Part I. The interferons.
    Balmer CM
    DICP; 1990; 24(7-8):761-8. PubMed ID: 1695795
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cancer immunotherapy: the interferon-alpha experience.
    Kirkwood J
    Semin Oncol; 2002 Jun; 29(3 Suppl 7):18-26. PubMed ID: 12068384
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Interferon-alpha-induced psoriasis vulgaris].
    Wölfer LU; Goerdt S; Schröder K; Zouboulis CC; Orfanos CE
    Hautarzt; 1996 Feb; 47(2):124-8. PubMed ID: 8868456
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interferons in dermatology. Present-day standard.
    Stadler R
    Dermatol Clin; 1998 Apr; 16(2):377-98. PubMed ID: 9589211
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intralesional interferon alfa-2b treatment of condylomata acuminata previously resistant to podophyllum resin application.
    Boot JM; Blog FB; Stolz E
    Genitourin Med; 1989 Jan; 65(1):50-3. PubMed ID: 2921053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.